JPMorgan raised the firm’s price target on Molecular Partners to CHF 4.50 from CHF 3.70 and keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLLCF: